What is the Best Scar Removal Cream for C-section?

December 19, 2025 6:00 AM

With nearly 1.2 million cesarean deliveries performed annually in the United States alone, representing nearly 32% of all births, the demand for effective C-section scar treatment is always high. Scar Protocol, a multi-phase topical scar care system developed by a Seattle plastic surgeon, Dr. Javad Sajan, is being positioned as an option made specifically for postpartum scar care following cesarean delivery.The C-Section Scar ChallengeC-section...

Read more

Hootan Troy Farahmand: Leading With Purpose and Compassion in Modern Healthcare

December 18, 2025 5:45 PM

As the healthcare landscape evolves, leaders who combine business strength with human-centered values are becoming increasingly vital. Among them, Hootan Troy Farahmand stands out as a steady force shaping a future in which access, dignity, and responsible care guide corporate growth. As Chief Executive Officer of Alexso, Inc., a nationwide pharmaceutical distributor, Farahmand has earned recognition for pairing strategic leadership with...

Read more

Trump Orders Marijuana Research Expansion - MMJ Already Has the Medicine

December 18, 2025 5:05 PM

Following today's White House announcement and Fact Sheet, "President Donald J. Trump Is Increasing Medical Marijuana and Cannabidiol Research," MMJ International Holdings, Inc. confirmed it has completed development of its final dose form pharmaceutical soft-gel cannabinoid capsules. These capsules are validated, reproducible, manufactured to pharmaceutical GMP standards, and are awaiting final FDA authorization for use in federally approved...

Read more

NHI Announces $89.2 Million in Investments and Updates Pipeline

December 18, 2025 5:00 PM

National Health Investors, Inc. (NYSE:NHI) announced today that it has invested $89.2 million, including transaction costs, in four separate transactions at an average initial yield of 8.20%.The investments include the following:$52.1 million, including transaction costs, for the acquisition of a 107-unit assisted living and memory care community in Jamison, PA operated by Priority Life Care ("PLC") which is a new relationship for NHI. The...

Read more

Glioblastoma Foundation Expands Scientific Leadership as It Prepares to Accept Patient Samples for Universal Genomic Testing

December 18, 2025 4:40 PM

Today, the Glioblastoma Foundation announced the appointment of three distinguished scientific leaders to the Genomic Laboratory team as the Foundation completes validation of its state-of-the-art genomic testing program and prepares to accept patient samples in the coming weeks.Ferrin Wheeler, PhD, FACMG, has joined the Glioblastoma Foundation as Laboratory Director of the CLIA-certified clinical genomic testing laboratory. Dr. Wheeler brings...

Read more

Babson Diagnostics Wins Best Abstract Award at 2025 EFLM Preanalytical Conference

December 18, 2025 1:10 PM

Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, presented scientific posters on automation and hemolysis at the 7th EFLM conference on preanalytical phase in Padova, Italy on December 12-13, 2025. Babson received a Best Abstract award for its poster titled "Use of automation to reduce error in sample preparation."Preanalytical errors, or errors that occur before the sample arrives at the...

Read more

The 'sam Recovery Sideline Challenge' for College and Professional Sports Teams Enters Home Stretch

December 18, 2025 9:05 AM

College and professional sports teams nationwide are pushing toward the finish of the sam® Recovery Sideline Challenge, showing how they use the ZetrOZ Systemssam® wearable ultrasound device to keep their athletes healthy. Through December 29, teams' athletic trainers can log the hours that their athletes have used the sam® sustained acoustic medicine device to treat injuries and recover faster. Teams should log their hours using the forms...

Read more

Aytu BioPharma to Host Investor Day on January 20, 2026 in New York City

December 18, 2025 9:00 AM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, will be hosting an Investor Day on Tuesday, January 20, 2026, at 11:00 a.m. Eastern time in New York City.The Investor Day will include presentations from Aytu's senior leadership and discussions with Key Opinion Leaders ("KOLs")...

Read more

The Menninger Clinic Announces $1 Million Gift to Establish Adolescent Patient Assistance Fund

December 18, 2025 9:00 AM

A landmark $1 million philanthropic gift to The Menninger Clinic establishes a new Adolescent Patient Assistance Fund that will help adolescents ages 12-17 gain access to high quality mental health treatment who lack the necessary financial resources. The anonymous donor has expressed hope that their contribution will encourage others to support the fund, recognizing the heightened levels of mental illnesses such as anxiety, depression and...

Read more

Xcelerate Issues Year-End Update on Strategic Focus and 2026 Plans

December 18, 2025 8:30 AM

Management of Xcelerate, Inc. (OTCID:XCRT) today issued a year-end update on key developments in 2025 and the Company's strategic priorities for 2026. As 2025 comes to a close, Xcelerate has taken decisive steps to align its resources with the Company's long-term objectives. By the start of the year, the Company determined that while ESN Group had an excellent product line, it required significantly more cash than Xcelerate was able to provide...

Read more

Aspire Biopharma Welcomes Elite Ultra-Runner Ashley Paulson as Global Brand Ambassador for BUZZ BOMB(R) Caffeine

December 18, 2025 8:30 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a leader in innovative supplement delivery systems, is proud to announce that professional ultra-marathoner and Ironman champion Ashley Paulson has joined Aspire as the official Brand Ambassador for BUZZ BOMB™, the Company's premier sublingual caffeine product.Ashley Paulson: Endurance Athlete and BUZZ BOMB™ AmbassadorAshley Paulson is a world-class endurance athlete,...

Read more

Telomir Pharmaceuticals Reports Favorable IND-Enabling GLP Safety Results for Telomir-1 Supporting First-in-Human Clinical Development

December 18, 2025 7:30 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a preclinical-stage biotechnology company developing therapies that target epigenetic and metabolic drivers of cancer and age-related disease, today announced favorable results from a comprehensive series of IND-enabling Good Laboratory Practice (GLP) toxicology and safety pharmacology studies for its lead therapeutic candidate, Telomir-1 (Zn-Telomir).The studies were...

Read more

CEPI to Fund Pivotal Phase 3 Trial for Moderna's mRNA Pandemic Influenza Vaccine Candidate

December 18, 2025 7:00 AM

OSLO, NORWAY and CAMBRIDGE, MA / ACCESS Newswire / December 18, 2025 / The Coalition for Epidemic Preparedness Innovations (CEPI) will invest up to $54.3 million to support a pivotal Phase 3 clinical trial that aims to help advance Moderna's investigational mRNA-based H5 pandemic influenza vaccine candidate, mRNA-1018, to licensure. The funding marks a significant step forward in global pandemic preparedness that could enable fast, equitable...

Read more

Hemogenyx Pharmaceuticals PLC - Issue of Equity

December 18, 2025 2:10 AM

Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")Issue of Equity arising from the Exercise of Warrants, Restricted Stock Unit Award and Deed of Variation And Total Voting RightsIntroductionHemogenyx Pharmaceuticals plc (LSE:HEMO) announces that it has issued and allotted an aggregate of 123,377 new Ordinary Shares of 1p each ("Ordinary Shares") in the Company for the reasons set out in this announcement.Warrant...

Read more

1933 Industries Announces Maturity of Unsecured Convertible Debentures and Encourages Conversion to Support Continued Growth

December 18, 2025 12:25 AM

1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCID:TGIFF), a Nevada-focused cannabis cultivator and producer, announces that its unsecured convertible debentures issued in 2024 (the "2024 Debentures"), with an aggregate principal amount of approximately $2,598,000 in principal value, will mature on December 31, 2025.Following a careful review of the Company's financial position, operating performance, and near-term...

Read more

CORRECTION: TruMerit and NAPNAP Team Up to Develop a Global Micro-credential for Pediatric Nursing Care

December 17, 2025 5:30 PM

TruMerit, a worldwide leader in international credentials evaluation to support health worker careers, and the National Association of Pediatric Nurse Practitioners (NAPNAP), The Leader in Pediatric Education for Nurse Practitioners®, have announced they will jointly develop a global micro-credential to help advance the knowledge and skills of the world's pediatric nursing workforce.The collaboration aims to improve health outcomes for infants,...

Read more

BenCura University: Elevating Care, One Course at a Time

December 17, 2025 4:00 PM

Innovation in healthcare doesn't happen by accident, it happens by design. As regulations evolve, reimbursement models shift, and patient needs grow more complex, frontline teams need more than updates; they need practical, high-impact learning that turns change into better care. That's why we've created BenCura University, a focused on-line and on-site education platform for therapists, nurses, CNAs, leaders, and the full IDT."Our goal is to...

Read more

Mind Vault Reviews (URGENT REPORT) Why This Cognitive Formula Is Trending With Adults Over 45 in 2025

December 17, 2025 4:00 PM

Cognitive health anxiety is quietly rising among adults over 45, and in 2025, that concern has pushed one name to the top of search trends: Mind Vault. As more people notice memory slips, slower recall, and mental fatigue creeping into daily life, interest has surged around senior-focused brain supplements that promise calm focus without harsh stimulants. But popularity alone doesn't equal credibility. This urgent report examines why Mind Vault...

Read more

Trumps Marijuana Reclassification is Only the Beginning: Why MMJ International Holdings Takes the Lead in the Medicare and Research Reset

December 17, 2025 3:00 PM

As President Donald Trump considers an executive order to reclassify cannabis to Schedule III and potentially authorize limited Medicare pilot programs MMJ International Holdings today clarified the regulatory reality of this shift: any cannabinoid reimbursed by Medicare must comply with the FDA's rigorous drug approval framework, not the unregulated dietary supplement market.The anticipated policy shift would mark a definitive end to the era of...

Read more

TruMerit and NAPNAP Team Up to Develop a Global Micro-credential for Pediatric Nursing Care

December 17, 2025 12:45 PM

TruMerit, a worldwide leader in international credentials evaluation to support health worker careers, and the National Association of Pediatric Nurse Practitioners (NAPNAP), The Leader in Pediatric Education for Nurse Practitioners®, have announced they will jointly develop a global micro-credential to help advance the knowledge and skills of the world's pediatric nursing workforce.The collaboration aims to improve health outcomes for infants,...

Read more